Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Active, not recruiting · NCT04396808 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2026-09-09 | NCT04396808 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MDx Health | 2 |
| Myrexis Inc. | 1 |
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
| University of Michigan Rogel Cancer Center | 63 |
| Veracyte, Inc. | 8 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henry Ford Health System | Detroit | United States | 147 |
| Montefiore Medical Center | The Bronx | United States | 79 |
| Sherwood Medical Center | Detroit | United States | 1 |
| Spectrum Health Medical Group | Grand Rapids | United States | 3 |
| University of Michigan Rogel Cancer Center | Ann Arbor | United States | 186 |
| University of North Carolina | Chapel Hill | United States | 101 |
| University of Pennsylvania Perelman School of Medicine | Philadelphia | United States | 10 |
| Western Michigan Urological Associates | Holland | United States | 1 |